Voyager Therapeutics Inc Stock
Price
Target price
€8.80
€8.80
-1.080%
-0.1
-1.080%
€16.00
27.03.24 / Tradegate
WKN: A143XJ / Name: Voyager / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Voyager Therapeutics Inc Stock
We can see a decrease in the price for Voyager Therapeutics Inc. Compared to yesterday it has lost -€0.100 (-1.080%).
Currently there is a rather positive sentiment for Voyager Therapeutics Inc with 3 Buy predictions and 0 Sell predictions.
With a target price of 16 € there is a hugely positive potential of 81.82% for Voyager Therapeutics Inc compared to the current price of 8.8 €.
Our community identified positive and negative aspects for Voyager Therapeutics Inc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Voyager Therapeutics Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Voyager Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Voyager Therapeutics Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Voyager Therapeutics Inc | -1.080% | 1.149% | 6.024% | 29.450% | 10.692% | 114.634% | - |
Salarius Pharmaceuticals Inc. | 1.470% | -18.824% | -22.617% | -76.389% | -25.405% | -98.665% | -99.992% |
Ardelyx Inc. | -1.160% | -6.371% | -22.654% | 73.980% | 16.955% | 25.791% | - |
Evolus Inc | -0.770% | 2.362% | -2.985% | 66.667% | 39.037% | 31.287% | - |
News
Voyager Therapeutics stock pops 30% on deal with Novartis
Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with